Eye

Journal Title：Eye

Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists.

Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease; oculo-plastic surgery; orbital and lacrimal disease; ocular surface and corneal disorders; paediatric ophthalmology and strabismus; glaucoma; medical and surgical retina; neuro-ophthalmology; cataract and refractive surgery; ocular oncology; ophthalmic pathology; ophthalmic genetics.

Eye 致力于为国际执业眼科医生提供高质量的文章，这些文章具有学术严谨性，涉及最新的全球临床和实验室研究。其核心目标是利用最新的临床和科学研究推动眼科学和实践的发展。虽然该期刊主要针对执业临床医生，但它包含的材料引起了更广泛读者的兴趣，包括验光师、斜视矫正师、其他医疗保健专业人员以及全球视觉科学领域各个方面的研究人员。Eye 是皇家眼科学院的官方期刊。

Eye 鼓励提交原创文章，涵盖眼科的各个方面，包括：外眼疾病；眼整形手术；眼眶和泪腺疾病；眼表和角膜疾病；儿科眼科和斜视；青光眼；医学和外科视网膜；神经眼科；白内障和屈光手术；眼肿瘤学；眼科病理学；眼科遗传学。

Eye创刊于1987年，由Springer Nature出版商出版，收稿方向涵盖医学 - 眼科学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 一般,3-6周 ，影响因子指数2.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。